Indication

Serratia joint infection

A Serratia joint infection is an uncommon form of septic arthritis caused by Gram-negative opportunistic bacilli of the genus *Serratia*, most frequently *Serratia marcescens*. Read more about Serratia joint infection

65 drugs 47 manufacturers

Advertisement

Drugs that treat it

Common Serratia joint infection therapies.

Showing 37–45 of 65 drugs

Filter & compare in the drug finder →Opens the drug finder with Serratia joint infection preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Serratia joint infection.

A Serratia joint infection is an uncommon form of septic arthritis caused by Gram-negative opportunistic bacilli of the genus *Serratia*, most frequently *Serratia marcescens*.

It primarily affects the musculoskeletal system, involving native or prosthetic joints—such as the knee, shoulder, or fibrocartilaginous axial joints—frequently arising via hematogenous dissemination, direct iatrogenic inoculation, or trauma in immunocompromised hosts, hospitalized patients, and individuals with intravenous drug use.

Clinically and pathophysiologically, the organism colonizes the synovial membrane and space, eliciting intense neutrophil infiltration and inflammatory effusion that manifest as acute articular pain, swelling, erythema, and functional limitation.

If untreated, release of proteolytic enzymes and bacterial toxins within the closed joint space leads to rapid cartilage destruction and contiguous osteomyelitis.

Personalize your experience

Follow Serratia joint infection and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it